From benign airway lesions to bioengineered solutions: 3D bioprinting in tracheobronchopathia osteochondroplastica
Monaldi Archives for Chest Disease · 21.07.2026
DOI: 10.4081/monaldi.2026.3846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monaldi Archives for Chest Disease, online erschienen am 21.07.2026. Verfasst von Haris Hanif. Beteiligte Einrichtung: Department of Internal Medicine Unit III, Lahore General Hospital. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tracheobronchopathia osteochondroplastica is a rare benign lesion of the airways often managed conservatively. However, advanced obstruction requires reconstruction. This brief commentary explores the emerging role of 3D bioprinting as a curative solution, analyzing recent findings regarding mesenchymal stem cell-laden grafts and identifying vascularization as the critical hurdle preventing clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine Unit III, Lahore General Hospital.
Zitieren
APA
Hanif, H. (2026). From benign airway lesions to bioengineered solutions: 3D bioprinting in tracheobronchopathia osteochondroplastica. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2026.3846
Vancouver
Hanif H. From benign airway lesions to bioengineered solutions: 3D bioprinting in tracheobronchopathia osteochondroplastica. Monaldi Archives for Chest Disease. 2026. doi:10.4081/monaldi.2026.3846
BibTeX
@article{Hanif2026,
author = {Hanif, Haris},
title = {From benign airway lesions to bioengineered solutions: 3D bioprinting in tracheobronchopathia osteochondroplastica},
journal = {Monaldi Archives for Chest Disease},
year = {2026},
doi = {10.4081/monaldi.2026.3846}
}
EUVIMED